Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration. [electronic resource]
Producer: 20131025Description: 846-53 p. digitalISSN:- 1539-2864
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Choroid Diseases -- drug therapy
- Combined Modality Therapy
- Endotamponade
- Female
- Fibrinolytic Agents -- therapeutic use
- Fluorocarbons -- administration & dosage
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Photochemotherapy
- Polyps -- drug therapy
- Prone Position
- Ranibizumab
- Retinal Hemorrhage -- drug therapy
- Retrospective Studies
- Tissue Plasminogen Activator -- therapeutic use
- Tomography, Optical Coherence
- Visual Acuity -- physiology
- Wet Macular Degeneration -- complications
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.